Back to Journals » Lung Cancer: Targets and Therapy » Volume 8

Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting

Total article views   HTML views PDF downloads Totals
9,663 Dovepress* 8,322+ 1,072 9,394
PubMed Central* 1,341 353 1,694
Totals 9,663 1,425 11,088
*Since 19 October 2017
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 1 0 1

View citations on PubMed Central and Google Scholar